APPLIED GENETIC TECHNOLOGIES CORP Operating Cash Flow
APPLIED GENETIC TECHNOLOGIES CORP reported Operating Cash Flow of -$16.04 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-21
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$16.04M.
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$18.26M.
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$14.00M.
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$17.56M.
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for fiscal 2022 was -$65.75M.
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for fiscal 2021 was -$51.17M.
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for fiscal 2020 was -$41.62M.
- APPLIED GENETIC TECHNOLOGIES CORP net cash provided by (used in) operating activities for fiscal 2019 was -$23.46M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$16.04M 10-Q · filed 2022-11-21 | -$34.30M derived: sum of 2 quarters · filed 2022-11-21 | -$48.29M derived: sum of 3 quarters · filed 2022-11-21 | -$65.85M derived: sum of 4 quarters · filed 2022-11-21 |
| 2022-06-30 | -$18.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$32.26M derived: sum of 2 quarters · filed 2022-09-27 | -$49.81M derived: sum of 3 quarters · filed 2022-09-27 | -$65.75M 10-K · filed 2022-09-27 |
| 2022-03-31 | -$14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$31.55M derived: sum of 2 quarters · filed 2022-05-16 | -$47.49M 10-Q · filed 2022-05-16 | -$60.92M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-12-31 | -$17.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$33.49M 10-Q · filed 2022-02-14 | -$46.93M derived: sum of 3 quarters · filed 2022-11-21 | -$58.36M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-09-30 | -$15.94M 10-Q · filed 2022-11-21 | -$29.37M derived: sum of 2 quarters · filed 2022-11-21 | -$40.80M derived: sum of 3 quarters · filed 2022-11-21 | -$54.19M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | -$13.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$24.86M derived: sum of 2 quarters · filed 2022-09-27 | -$38.26M derived: sum of 3 quarters · filed 2022-09-27 | -$51.17M 10-K · filed 2022-09-27 |
| 2021-03-31 | -$11.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$24.82M derived: sum of 2 quarters · filed 2022-05-16 | -$37.74M 10-Q · filed 2022-05-16 | -$51.50M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$13.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$26.31M 10-Q · filed 2022-02-14 | -$40.07M derived: sum of 3 quarters · filed 2022-02-14 | -$48.89M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | -$12.92M 10-Q · filed 2021-11-09 | -$26.68M derived: sum of 2 quarters · filed 2021-11-09 | -$35.50M derived: sum of 3 quarters · filed 2021-11-09 | -$43.82M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$13.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | -$22.58M derived: sum of 2 quarters · filed 2021-09-23 | -$30.91M derived: sum of 3 quarters · filed 2021-09-23 | -$41.62M 10-K · filed 2021-09-23 |
| 2020-03-31 | -$8.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | -$17.14M derived: sum of 2 quarters · filed 2021-05-17 | -$27.85M 10-Q · filed 2021-05-17 | -$35.39M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | -$19.04M 10-Q · filed 2021-02-11 | -$26.57M derived: sum of 3 quarters · filed 2021-02-11 | -$33.52M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-09-30 | -$10.71M 10-Q · filed 2020-11-16 | -$18.25M derived: sum of 2 quarters · filed 2020-11-16 | -$25.20M derived: sum of 3 quarters · filed 2020-11-16 | -$34.76M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$7.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | -$14.48M derived: sum of 2 quarters · filed 2020-09-18 | -$24.04M derived: sum of 3 quarters · filed 2020-09-18 | -$23.46M 10-K · filed 2020-09-18 |
| 2019-03-31 | -$6.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | -$16.50M derived: sum of 2 quarters · filed 2020-05-13 | -$15.92M 10-Q · filed 2020-05-13 | -$22.66M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$9.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-05 | -$8.98M 10-Q · filed 2020-02-05 | -$15.72M derived: sum of 3 quarters · filed 2020-02-05 | -$23.00M derived: sum of 4 quarters · filed 2020-02-05 |
| 2018-09-30 | $583.00K 10-Q · filed 2019-11-12 | -$6.16M derived: sum of 2 quarters · filed 2019-11-12 | -$13.44M derived: sum of 3 quarters · filed 2019-11-12 | -$23.29M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | -$14.02M derived: sum of 2 quarters · filed 2019-09-26 | -$23.87M derived: sum of 3 quarters · filed 2019-09-26 | -$32.52M 10-K · filed 2019-09-26 |
| 2018-03-31 | -$7.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | -$17.13M derived: sum of 2 quarters · filed 2019-05-07 | -$25.78M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | -$9.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | -$18.50M 10-Q · filed 2019-02-07 | ||
| 2017-09-30 | -$8.65M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | -$31.00M 10-K · filed 2018-09-11 | |||
| 2016-06-30 | $70.99M 10-K · filed 2018-09-11 |